ФИЛАДЕЛЬФИЯ. Понедельник на BIO начинается во вторник. Крупнейшее ежегодное событие для биомедицинской индустрии, которое в нынешнем году проходит в Филадельфии, по традиции стартовало с партнеринга, и только на следующий день открылась выставка участников...
Wallarm , a Skolkovo resident company that provides AI-powered application security, announced Monday that it had closed an $8 million series A financing round in San Francisco, bringing the company’s total funding raised to $10.8 million. Members...
For many Russian tech startups, the colossal U.S. market with its abundance of investors seems like the promised land. The U.S. also happens to be the Skolkovo Foundation’s most active partner, the foundation’s president Victor Vekselberg told foreign...
Skolkovo resident startup ExoAtlet , which makes rehabilitation exoskeletons that help disabled people to walk again, has raised $5 million in investment to expand its business to Europe and beyond. The funding is being provided by the Korean company Cosmo...
Four Skolkovo biomed startups have obtained sponsorship from Johnson & Johnson, and met with the U.S. multinational’s executive vice president and chief scientific officer Paul Stoffels during his recent visit to the innovation centre. Skolkovo...
When tech startups are being considered for resident status at the Skolkovo innovation centre, one of the conditions for acceptance is that their product or service must have potential for export. Skolkovo’s mission is not import substitution; on the...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...